Osteomyelitis: Clinical Trials

7 trials for Osteomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 11Completed 1
Phase 31Completed 1

Follow Osteomyelitis: new trials by email Literature Review of Osteomyelitis trials Research Report on Osteomyelitis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)
Tedizolid - Bone and Joint Infection
Phase 2CompletedLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center442017-02-062023-12-13
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
MBN-101, Placebo - Bacterial Infection
Phase 2CompletedMicrobion Corporation292016-05-242021-09-30
Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
Dalbavancin, Comparator - Osteomyelitis
Phase 2CompletedDurata Therapeutics Inc., an affiliate of Allergan plc802016-03-152019-01-04
Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections
sodium fusidate - Refractory Bone or Joint Infections
Phase 2 / Phase 3CompletedArrevus Inc.302015-12-012020-01-30
Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Ceftaroline Fosamil - Hematogenously Acquired Staphylococcus Aureus Osteomyelitis, Bone Infection
Phase 1 / Phase 2CompletedBaylor College of Medicine112015-06-032021-11-02
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Feraheme, Magnetic Resonance Imaging (MRI) scan - Bone Cancer, Chondrosarcoma
Phase 2CompletedHeike E Daldrup-Link322011-08-012023-12-27
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci
daptomycin, vancomycin, teicoplanin - Osteomyelitis
Phase 2CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)752007-06-262018-01-31

Narrower conditions

Bacterial Infections (1)  ·  Bone Neoplasms (1)  ·  Chondrosarcoma (1)  ·  Fractures, Bone (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Osteonecrosis (1)  ·  Osteosarcoma (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Bone Diseases (7)  ·  Bone Diseases, Infectious (7)  ·  Musculoskeletal Diseases (7)  ·  Infections (6)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Bacterial Infections and Mycoses (1)  ·  Myosarcoma (1)  ·  Necrosis (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)

Interventions

Ceftaroline (1)  ·  Daptomycin (1)  ·  Ferrosoferric Oxide (1)  ·  Floxacillin (1)  ·  Fusidic Acid (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nafcillin (1)  ·  Oxacillin (1)  ·  Teicoplanin (1)  ·  Vancomycin (1)  ·  dalbavancin (1)  ·  tedizolid (1)  ·  tedizolid phosphate (1)

Sponsors

Arrevus Inc. (1)  ·  Baylor College of Medicine (1)  ·  Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Durata Therapeutics Inc., an affiliate of Allergan plc (1)  ·  Heike E Daldrup-Link (1)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)  ·  Microbion Corporation (1)

Countries

United States (6)  ·  Russia (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Alistair Wheeler, MD (1)  ·  Brett Baker, MSc, DC (1)  ·  Heike E Daldrup-Link, MD (1)  ·  Loren G Miller, MD MPH (1)  ·  Neyssa Marina, MD (1)  ·  Robert Dobbins, MD, PhD (1)  ·  Sheldon L. Kaplan, MD (1)  ·  Urania Rappo, MD, MS, PharmD (1)

Results publications

PMID 22908174, PMID 30648126